Safety of intramuscular tixagevimab-cilgavimab (Evusheld^®) administration in patients at risk of iatrogenic haematoma due to haematological disorders

2024-9-17

Effect of zoledronic acid and pamidronate on renal function

2024-9-17

Letrozole-induced reversible acute heart failure

2024-9-13

Assessment of chemotherapy-related adverse drug reactions among multiple myeloma patients at Kenyatta national hospital

2024-9-5

Implementation of a pharmacist-guided pharmacogenomics dosing service at a rural NCI-designated comprehensive cancer center

2024-9-4

Enhancing access to expensive oncology medications in Pakistan: The critical role of pharmaceutical patient assistance programs in oncology care

2024-9-2

Assessment of drug-drug interactions among patients with hematologic malignancy: A clinical pharmacist-led study

2024-9-2

“The protective effect of nano curcumin supplementation on doxorubicin induced cardiotoxicity in breast cancer patients; a randomized, double-blind clinical trial”

2024-9-2

Successful desensitization to etoposide in a patient after cardiac arrest

2024-9-2

Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study

2024-9-2

Grade 3 cytolysis in a patient with metastatic colorectal cancer consuming a mushroom powder-based alternative therapy

2024-9-2

Managing medications for patients with cancer and chronic conditions: It's time for collaboration between primary care and oncology pharmacists

2024-8-30

Prolonged in-use physicochemical and biological stability of nivolumab and pembrolizumab diluted in saline infusion bags and in partially used medication vials

2024-8-30

Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy

2024-8-28

Docetaxel-induced severe neuropathy, a case of breast cancer with GTSP1 polymorphism

2024-8-28

Real-world experience of abemaciclib for adjuvant and metastatic breast cancer

2024-8-28

Novel genetic structures associated with adverse response to chemotherapy in breast cancer

2024-8-28

Examining clinical pharmacist interventions and identifying opioid medication-related issues in patients with cancer

2024-8-28

Safety and oncological effectiveness after desensitization in patients with previous hypersensitivity reactions to chemotherapy

2024-8-28

Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center

2024-8-28

Withdrawal pain following patients discontinuing Trk inhibitors

2024-8-27

Assessment of chemical contamination by cancer drugs during use of the RIVA^TM compounding robot: A pilot study

2024-8-26

Role of osteoclast inhibitors in prostate cancer bone metastasis; a narrative review

2024-8-22

Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies

2024-8-18

Predictors of fluid overload in allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide

2024-8-18

Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia

2024-8-16

Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report

2024-8-14

Trastuzumab-induced optic neuritis: “blindness” side effect

2024-8-14

Sjogren's syndrome due to immune checkpoint inhibitors (ICIs): Insights from a single-institution series and systematic review of the literature

2024-8-8

Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP)

2024-8-7

Evaluation of oral silymarin formulation efficacy in prevention of doxorubicin induced hepatotoxicity in patients with non-metastatic breast cancer

2024-8-7

Successful treatment of PD1-inhibitor induced psoriasiform dermatitis using IL-17 blockade without compromising immunotherapy efficacy

2024-8-7

Professional profile in veterinary oncology: A Brazilian nationwide survey

2024-8-6

Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast

2024-8-2

Pembrolizumab related perforated appendicitis

2024-8-2

Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia

2024-8-2

A longitudinal assessment of major mouthwashes used in alleviating pain and xerostomia among advanced nasopharyngeal carcinoma patients receiving chemoradiotherapy

2024-8-2

Oncology stewardship practice in the United States: A Hematology/Oncology Pharmacy Association national survey

2024-8-1

Safety outcomes of teclistamab accelerated dose escalation

2024-8-1

A comprehensive study of adverse effects of chemotherapy on female breast cancer patients in NORI Cancer Hospital, Islamabad in a developing country

2024-8-1

Incidence of hand-foot syndrome with protein kinase inhibitors in advanced hepatocellular carcinoma patients who received atezolizumab-bevacizumab combination

2024-8-1

Oral lichenoid drug eruption due to osimertinib for lung cancer

2024-8-1

A multifaceted role of bisphosphonates from palliative care to anti-cancer therapy in solid tumors

2024-7-26

Dostarlimab: A promising new PD-1 inhibitor for cancer immunotherapy

2024-7-26

The effect of examining somatic alterations with NGS in patients with solid tumors, on patient management: A single-center experience in Turkey

2024-7-25

A two-tool assessment of the quality of life of patients with breast cancer using generic and disease-specific tools in a Nigerian teaching hospital

2024-7-25

<i>In vitro</i> compatibility of admixture solutions of 5-fluorouracil and khapzory (disodium levofolinate) in a single infusion bag

2024-7-25

Trend analysis of pharmacist involvement in cancer care in Japan from 2015 to 2020: A nationwide survey study on hospital pharmacy practice

2024-7-25

Hypokalemia, hypomagnesemia, and hyponatremia are associated with acute kidney injury in patients treated with cisplatin

2024-7-25

Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies

2024-7-25